19
Participants
Start Date
October 31, 2011
Primary Completion Date
February 28, 2015
Study Completion Date
February 10, 2015
ABT-888/Bortezomib
ABT-888 is given orally (PO) twice daily (every 12 hours) for 14 days in a 21 days cycle. First dose to be given within 1 hour of Bortezomib on day 1. Planned starting dose is 20 mg PO every 12 hours. Starting dose escalation is planned until an MTD is reached.
Tom Baker Cancer Centre, Calgary
Collaborators (1)
Tom Baker Cancer Centre
OTHER
Abbott
INDUSTRY
AHS Cancer Control Alberta
OTHER